Skip to search.
 TSX Up 0.20% TSX Ventures Down 0.34%

Seattle Genetics, Inc. (SGEN)

-NasdaqGS
36.00 Down 0.25(0.69%) Mar 2, 4:00PM EST
Add to Portfolio
Prev Close:36.25
Open:36.61
Bid:30.75 x 400
Ask:64.86 x 100
1y Target Est:43.20
Beta:2.4
Earnings Date:Apr 29 - May 4 (Est.)
Day's Range:35.54 - 37.29
52wk Range:30.05 - 55.46
Volume:1,372,459
Avg Vol (3m):1,376,480
Market Cap:4.46B
P/E (ttm):N/A
EPS (ttm):-0.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
SGENDown 0.69%4.46B
IMGNUp 3.82%679.38M
PFEUp 1.31%213.10B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.67
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.71
Quarterly EPS Est (Mar-15) :-0.19
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-2.02

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback